Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease

NCT01118754 is registered in ClinicalTrials.gov with Santen Inc. as lead sponsor.

NCT NCT01118754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Prospective, Randomized, Double Masked, Parallel-Group, Multi-centered Study Assessing the Safety and Efficacy of Two Concentrations of DE-101 Compared to Placebo for the Treatment of Dry Eye Disease
Lead sponsor
Santen Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2010
Completion date
December 31, 2010
Enrollment
132 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye